Terms: = Leukemia AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Clinical Outcome
41 results:
1. SOX2 downregulation of pml increases HCMV gene expression and growth of glioma cells.
Wen L; Wang XZ; Qiu Y; Zhou YP; Zhang QY; Cheng S; Sun JY; Jiang XJ; Rayner S; Britt WJ; Chen J; Hu F; Li FC; Luo MH; Cheng H
PLoS Pathog; 2023 Apr; 19(4):e1011316. PubMed ID: 37058447
[TBL] [Abstract] [Full Text] [Related]
2. Co-occurrence of pml-RARA gene fusion, chromosome 8 trisomy, and FLT3 ITD mutation in a young female patient with de novo acute myeloid leukemia and early death: A CARE case report.
Tripon F; Crauciuc GA; Bogliş A; Moldovan V; Sándor-Kéri J; Benedek IJ; Trifa AP; Bănescu C
Medicine (Baltimore); 2020 Apr; 99(14):e19730. PubMed ID: 32243411
[TBL] [Abstract] [Full Text] [Related]
3. Progressive multifocal leukoencephalopathy: A 25-year retrospective cohort study.
Anand P; Hotan GC; Vogel A; Venna N; Mateen FJ
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31554669
[TBL] [Abstract] [Full Text] [Related]
4. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential outcome Predictor.
Thurnher MM; Boban J; Rieger A; Gelpi E
AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
[TBL] [Abstract] [Full Text] [Related]
5. Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid leukemia.
Schemionek M; Kharabi Masouleh B; Klaile Y; Krug U; Hebestreit K; Schubert C; Dugas M; Büchner T; Wörmann B; Hiddemann W; Berdel WE; Brümmendorf TH; Müller-Tidow C; Koschmieder S
PLoS One; 2015; 10(5):e0125783. PubMed ID: 25996952
[TBL] [Abstract] [Full Text] [Related]
6. A novel clonal t(1;4)(p36.1;q31) translocation in acute promyelocytic leukaemia.
Zhang X; Pan J
J Clin Pathol; 2015 May; 68(5):391-3. PubMed ID: 25759405
[TBL] [Abstract] [Full Text] [Related]
7. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
[TBL] [Abstract] [Full Text] [Related]
8. [clinical investigation of homoharringtonine in combination with all-transretinoic acid and arsenic trioxide for acute promyelocytic leukemia].
Pei RZ; Li SY; Zhang PS; Ma JX; Liu XH; Du XH; Chen D; Sha KY; Chen LG; Cao JJ; Zhuang XX; Wu JY; Lin L; Fan Z; Ye PP; Tang SH; Zhang BB; Shi XW
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):144-8. PubMed ID: 23611222
[TBL] [Abstract] [Full Text] [Related]
9. Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.
Chen SJ; Zhou GB
IUBMB Life; 2012 Aug; 64(8):671-5. PubMed ID: 22714999
[TBL] [Abstract] [Full Text] [Related]
10. The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?
Ablain J; Nasr R; Bazarbachi A; de Thé H
Cancer Discov; 2011 Jul; 1(2):117-27. PubMed ID: 22586354
[TBL] [Abstract] [Full Text] [Related]
11. Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.
Schiller J; Praulich I; Krings Rocha C; Kreuzer KA
Eur J Haematol; 2012 Jul; 89(1):53-62. PubMed ID: 22458420
[TBL] [Abstract] [Full Text] [Related]
12. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia.
Shen Y; Zhu YM; Fan X; Shi JY; Wang QR; Yan XJ; Gu ZH; Wang YY; Chen B; Jiang CL; Yan H; Chen FF; Chen HM; Chen Z; Jin J; Chen SJ
Blood; 2011 Nov; 118(20):5593-603. PubMed ID: 21881046
[TBL] [Abstract] [Full Text] [Related]
13. FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia: a study of 531 Southeast Asian children by the Ma-Spore study group.
Leow S; Kham SK; Ariffin H; Quah TC; Yeoh AE
Hematol Oncol; 2011 Dec; 29(4):211-9. PubMed ID: 21387358
[TBL] [Abstract] [Full Text] [Related]
14. clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
Mrózek K; Bloomfield CD
J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
[TBL] [Abstract] [Full Text] [Related]
15. Acute promyelocytic leukemia: from highly fatal to highly curable.
Wang ZY; Chen Z
Blood; 2008 Mar; 111(5):2505-15. PubMed ID: 18299451
[TBL] [Abstract] [Full Text] [Related]
16. [Molecular responses in acute promyelocytic leukemia patients monitored by real-time quantitative RT-PCR].
Yao L; Chen ZX; Cen JN
Ai Zheng; 2008 Feb; 27(2):214-7. PubMed ID: 18279625
[TBL] [Abstract] [Full Text] [Related]
17. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.
Zhou GB; Li G; Chen SJ; Chen Z
Acta Pharmacol Sin; 2007 Sep; 28(9):1434-49. PubMed ID: 17723177
[TBL] [Abstract] [Full Text] [Related]
18. Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen.
Mathews V; Thomas M; Srivastava VM; George B; Srivastava A; Chandy M
Haematologica; 2007 Jul; 92(7):994-5. PubMed ID: 17606455
[TBL] [Abstract] [Full Text] [Related]
19. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond.
Hu J; Zhou GB; Wang ZY; Chen SJ; Chen Z
Adv Cancer Res; 2007; 98():191-220. PubMed ID: 17433911
[TBL] [Abstract] [Full Text] [Related]
20. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract] [Full Text] [Related]
[Next]
